1. Home
  2. LEGN vs ERJ Comparison

LEGN vs ERJ Comparison

Compare LEGN & ERJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • ERJ
  • Stock Information
  • Founded
  • LEGN 2014
  • ERJ 1969
  • Country
  • LEGN United States
  • ERJ Brazil
  • Employees
  • LEGN N/A
  • ERJ N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • ERJ Aerospace
  • Sector
  • LEGN Health Care
  • ERJ Industrials
  • Exchange
  • LEGN Nasdaq
  • ERJ Nasdaq
  • Market Cap
  • LEGN 7.0B
  • ERJ 8.6B
  • IPO Year
  • LEGN 2020
  • ERJ 2000
  • Fundamental
  • Price
  • LEGN $29.20
  • ERJ $49.76
  • Analyst Decision
  • LEGN Strong Buy
  • ERJ Buy
  • Analyst Count
  • LEGN 13
  • ERJ 5
  • Target Price
  • LEGN $79.42
  • ERJ $48.75
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • ERJ 1.2M
  • Earning Date
  • LEGN 05-13-2025
  • ERJ 05-06-2025
  • Dividend Yield
  • LEGN N/A
  • ERJ 0.10%
  • EPS Growth
  • LEGN N/A
  • ERJ 70.71
  • EPS
  • LEGN N/A
  • ERJ 0.52
  • Revenue
  • LEGN $728,303,000.00
  • ERJ $6,519,769,233.00
  • Revenue This Year
  • LEGN $65.96
  • ERJ N/A
  • Revenue Next Year
  • LEGN $52.55
  • ERJ $13.68
  • P/E Ratio
  • LEGN N/A
  • ERJ $94.16
  • Revenue Growth
  • LEGN 112.46
  • ERJ 39.31
  • 52 Week Low
  • LEGN $29.27
  • ERJ $25.24
  • 52 Week High
  • LEGN $60.87
  • ERJ $56.61
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 35.16
  • ERJ 65.08
  • Support Level
  • LEGN $29.40
  • ERJ $46.85
  • Resistance Level
  • LEGN $33.30
  • ERJ $50.01
  • Average True Range (ATR)
  • LEGN 1.56
  • ERJ 1.40
  • MACD
  • LEGN -0.27
  • ERJ 0.55
  • Stochastic Oscillator
  • LEGN 8.27
  • ERJ 92.31

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About ERJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

Share on Social Networks: